| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.075 | 0.1 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.076 | 0.1 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.1 |